The Daily Pulse: Key Developments in Science, Economics, and Donor Funding Date: Tuesday, April 8, 2025

Introduction

Staying informed about the latest developments in science, research, economics, business, entrepreneurship, and donor funding effectiveness is essential for strategic planning and informed decision-making. This newsletter highlights recent reports and funding opportunities shaping these sectors.

Introduction

Staying informed about the latest developments in science, research, economics, business, entrepreneurship, and donor funding effectiveness is essential for strategic planning and informed decision-making. This newsletter highlights recent reports and funding opportunities shaping these sectors.

1. U.S. Stock Market Faces Turbulence Amid New Tariffs

Published: April 4, 2025

U.S. stock futures are experiencing significant declines following President Donald Trump's announcement of new tariffs. China has retaliated with 34% tariffs on U.S. imports, effective April 10. The Nasdaq previously fell 6%, with futures indicating continued downturns; both the S&P 500 and Dow Jones are down approximately 3.5%. Economic data suggests a slowdown in the U.S. labor market, with a projected 140,000 new jobs in March compared to 151,000 in February, while unemployment remains steady at 4.1%. Business Insider+2Business Insider+2Investopedia+2Investopedia+1Business Insider+1

2. NIH Funding Delays Threaten Medical Research

Published: April 4, 2025

Significant delays and cancellations in National Institutes of Health (NIH) funding are jeopardizing vital scientific progress. Between October 2024 and February 2025, NIH withheld $1.8 billion in grants, reducing the renewal rate from over 98% to 45%. This has led to mass firings at health agencies and disruptions in ongoing projects, impacting critical research endeavors, including work on antiviral treatments. The pharmaceutical industry, which relies heavily on NIH-funded foundational research, faces long-term threats to drug discovery and innovation. Barron's

3. Meghan Markle Launches Lifestyle Brand 'As Ever'

Published: April 4, 2025

Meghan Markle officially launched her lifestyle brand, As Ever, unveiling nine home goods products priced between $14 and $28, which sold out within an hour. The brand underwent a name change from “American Riviera Orchard,” influenced by advice from Bumble founder Whitney Wolfe Herd. Partnering with Netflix's Consumer Products Group significantly shaped the brand's strategy, aligning with Meghan’s vision and expanding its reach. Vanity Fair

4. Investors Brace for Further Market Declines

Published: April 4, 2025

The U.S. stock market experienced its worst day in five years, with the S&P 500 dropping nearly 5%, the Dow falling by 1,679 points, and the Nasdaq losing 6%. Analysts predict that first-quarter earnings won't reflect the tariff impact, but future quarters likely will, potentially reducing S&P 500 earnings per share by 5% to 32%, especially if trading partners retaliate. Investors are advised to prepare for further declines amid ongoing economic uncertainties. Business Insider

5. Economists Criticize 'Liberation Day' Tariffs

Published: April 4, 2025

President Trump's "Liberation Day" tariffs have drawn strong criticism from leading economists and market analysts. Joshua Bolten of the Business Roundtable warned of major harm to American manufacturers and families, while economist Larry Summers labeled them a “$30 trillion” loss and the most "masochistic" policy in decades. The tariffs are expected to increase household costs by up to $5,000 annually and contribute to inflationary pressures. Business Insider

6. HHS Leadership Changes Raise Public Health Concerns

Published: April 4, 2025

The appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services has led to significant policy shifts, including downsizing infectious disease programs and amplifying misinformation, contributing to rising infection rates and vaccine skepticism. Massive layoffs, with 20,000 positions cut, have weakened the capacity of agencies like the CDC, FDA, and NIH, raising concerns about the nation's ability to manage public health effectively. Vox

7. Gavi's CEO Advocates for Continued U.S. Funding

Published: April 3, 2025

Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance, emphasized the critical importance of continued U.S. funding. The U.S. contributes approximately 13-14% of Gavi’s budget. Withdrawal of this support could result in 75 million children missing vaccinations and over a million potential deaths. Gavi plays a vital role in global health security, maintaining emergency vaccine stockpiles for outbreaks like Ebola and cholera. Time

8. Meta's Head of AI Research Steps Down

Published: April 2, 2025

Joelle Pineau, Meta's vice president for AI research, announced her decision to step down by the end of May, concluding an eight-year tenure at the company. Pineau has been instrumental in promoting Meta's open-source approach to AI technology, notably with the large language model, Llama. Her departure comes amid heightened competition in AI development. AP News

9. Microsoft's AI for Science Lab Highlights AI's Role in Scientific Discovery

Published: April 3, 2025

Christopher Bishop, head of Microsoft’s AI for Science lab, highlighted the transformative impact of artificial intelligence on scientific discovery. AI is accelerating breakthroughs in fields like chemistry, physics, biology, and climate science, addressing critical global issues such as drug discovery and energy development. Bishop emphasized AI’s role in empowering scientists and organizations, marking a new era of scientific inquiry. Financial Times+1arXiv+1

10. WHO Faces Significant Budget Shortfall

Published: April 2, 2025

The World Health Organization (WHO) is confronting a $1.9 billion funding gap, representing nearly 45% of its planned budget for the upcoming 2026-2027 period. This shortfall could severely impact global health initiatives and the organization's ability to respond to international health crises.